Alle Storys
Folgen
Keine Story von november Aktiengesellschaft mehr verpassen.

november Aktiengesellschaft

EANS-Adhoc: november AG Intends to Take Over neeb & partner GmbH, Darmstadt

  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
09.09.2010
Cologne, September 9, 2010
Today, november AG and alpha Vermögensverwaltungs- und 
Beteiligungsmanagement GmbH & Co. KG signed a letter of intent for 
the aquisition of 100% of the shares of neeb & partner GmbH, 
Darmstadt. The acqusition shall be executed within the next few weeks
through a capital increase against contribution in kind of a lower 
six-figure sum.
With the acquisition of neeb & partner GmbH the november AG expands 
its core competence with a specialized software and consulting 
company with focus on management systems for processes and documents 
in the pharmaceutical and biotech industry. Laboratories, scientific 
institutions and research institutes as well as the industrial 
research employ these systems for documentation and mapping of 
processes and workflows within quality assurance frameworks, 
certification and approval procedures. Customer references of neeb & 
partner include, inter alia, Aventis, Boehringer Ingelheim, Axal AG, 
Merck KGaA.
end of announcement                               euro adhoc

Further inquiry note:

Sabine Milobara
Tel.: +49 -(0) 221 8200 520 23
E-Mail: milobara@november.de

Branche: Biotechnology
ISIN: DE000A0Z24E9
WKN: A0Z24E
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade

Weitere Storys: november Aktiengesellschaft
Weitere Storys: november Aktiengesellschaft
  • 09.08.2010 – 10:39

    EANS-News: november Aktiengesellschaft

    Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. 6-month report Köln (euro adhoc) - Half-Year Results 2010 Confirm: november AG On Target Publication of consolidated operating results as of June 30, 2010 • PROGEN Biotechnik GmbH achieves positive operating results • Stable revenues of TEUR 1.806 • Consulting ...